首页> 外国专利> Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone

机译：包含抗CD38抗体的经临床验证的皮下药物组合物及其与硼替佐米和地塞米松的组合使用

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with bortezomib and dexamethasone.

机译：本发明涉及包含抗CD38抗体的经临床证实的皮下药物组合物及其与硼替佐米和地塞米松组合使用的方法。

著录项

公开/公告号US2020316197A1

专利类型
公开/公告日2020-10-08

原文格式PDF
申请/专利权人 JANSSEN BIOTECH INC.;
展开▼

申请/专利号US202016830810
发明设计人 RAJESH BANDEKAR;PAMELA CLEMENS;CHRISTOPH HEUCK;MING QI;ZHILONG YUAN;
展开▼

申请日2020-03-26
分类号A61K39/395;A61K38/47;A61K9;A61P35;A61K31/69;A61K31/573;
国家 US
入库时间 2022-08-21 11:21:30

相似文献

专利
外文文献
中文文献